Statistics for Glucagon-like peptide-1 agonists for treating obesity in patients with immune-mediated skin diseases
Total visits
| views | |
|---|---|
| Glucagon-like peptide-1 agonists for treating obesity in patients with immune-mediated skin diseases | 17 |
Total visits per month
| views | |
|---|---|
| November 2024 | 0 |
| December 2024 | 2 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| Vilarrasa_ad_gluc.pdf | 61 |
| Vilarrasa_ad_gluc.pdf(legacy) | 4 |
Top country views
| views | |
|---|---|
| United States | 7 |
| Spain | 3 |
| Japan | 3 |
| China | 1 |
| United Kingdom | 1 |
| Mongolia | 1 |
| Mexico | 1 |
Top city views
| views | |
|---|---|
| Mountain View | 4 |
| Barcelona | 3 |
| Tokyo | 3 |
| Ann Arbor | 1 |
| Menlo Park | 1 |
| Mexico | 1 |
| San Ramon | 1 |
| Shenzhen | 1 |
| Sükhbaatar | 1 |